Orlando Health, Inc.
Clinical trials sponsored by Orlando Health, Inc., explained in plain language.
-
Timing is everything: new trial challenges standard wait for pancreatitis procedure
Disease control Recruiting nowThis study compares early versus delayed endoscopic drainage in patients with infected necrotizing pancreatitis. About 104 adults with symptomatic, infected pancreatic fluid collections will be randomly assigned to receive the procedure within 4 weeks of disease onset or after th…
Phase: NA • Sponsor: Orlando Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New X-Ray tech aims to cut radiation risk in gut procedures
Knowledge-focused Recruiting nowThis study tests whether a newer type of X-ray machine (fluoroscopy system) can reduce radiation exposure during endoscopic procedures compared to the standard machine. About 108 patients and staff will be randomly assigned to one of the two systems. The main goal is to measure r…
Phase: NA • Sponsor: Orlando Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New registry to monitor endoscopic drainage for pancreatic complications
Knowledge-focused Recruiting nowThis study is a registry that will follow 1,000 people who receive standard endoscopic treatment for fluid collections caused by pancreatitis. The goal is to see how well the procedure works and what outcomes patients experience. No new treatment is being tested—this is about gat…
Sponsor: Orlando Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC